David Weill

Publications

• Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients. Dhillon GS, Valentine VG, Levitt J, Patel P, Gupta MR, Duncan SR, Seoane L, Weill D. Clin Transplant. 2012 Jan-Feb; 26 (1): 105-10
• Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis. Diamond JM, Lederer DJ, Kawut SM, Lee J, Ahya VN, Bellamy S, Palmer SM, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Shah PD, Weinacker A, Weill D, Kohl BA, Deutschman CC, Arcasoy S, Shah AS, Belperio JA, Wilkes D, Reynolds JM, Ware LB, Christie JD. Am J Transplant. 2011; 11 (11): 2517-22
• Lung function, radiological changes and exposure: analysis of ATSDR data from Libby, MT, USA. Weill D, Dhillon G, Freyder L, Lefante J, Glindmeyer H. Eur Respir J. 2011; 38 (2): 376-83
• Persistent racial disparities in survival after heart transplantation. Liu V, Bhattacharya J, Weill D, Hlatky MA. Circulation. 2011; 123 (15): 1642-9
• Racial disparities in survival after lung transplantation. Liu V, Weill D, Bhattacharya J. Arch Surg. 2011; 146 (3): 286-93
• A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients. Liu V, Dhillon GS, Weill D. Transpl Infect Dis. 2010; 12 (1): 38-44
• Increasing lung allocation scores predict worsened survival among lung transplant recipients. Liu V, Zamora MR, Dhillon GS, Weill D. Am J Transplant. 2010; 10 (4): 915-20
• Lung transplant airway hypoxia: a diathesis to fibrosis? Dhillon GS, Zamora MR, Roos JE, Sheahan D, Sista RR, Van der Starre P, Weill D, Nicolls MR. Am J Respir Crit Care Med. 2010; 182 (2): 230-6
• Review of heart-lung transplantation at Stanford. Deuse T, Sista R, Weill D, Tyan D, Haddad F, Dhillon G, Robbins RC, Reitz BA. Ann Thorac Surg. 2010; 90 (1): 329-37
• SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin. Chang W, Wei K, Jacobs SS, Upadhyay D, Weill D, Rosen GD. J Biol Chem. 2010; 285 (11): 8196-206
• Impact of hepatitis B core antibody positive donors in lung and heart-lung transplantation: an analysis of the United Network For Organ Sharing Database. Dhillon GS, Levitt J, Mallidi H, Valentine VG, Gupta MR, Sista R, Weill D. Transplantation. 2009; 88 (6): 842-6
• Popcorn lung and bronchiolitis obliterans: a critical appraisal. Galbraith D, Weill D. Int Arch Occup Environ Health. 2009; 82 (3): 407-16
• Substance P stimulates human airway submucosal gland secretion mainly via a CFTR-dependent process. Choi JY, Khansaheb M, Joo NS, Krouse ME, Robbins RC, Weill D, Wine JJ. J Clin Invest. 2009; 119 (5): 1189-200
• Effects of sinus surgery on lung transplantation outcomes in cystic fibrosis. Leung MK, Rachakonda L, Weill D, Hwang PH. Am J Rhinol. 2008 Mar-Apr; 22 (2): 192-6
• Comments on respiratory toxicity of diacetyl [Re: Morgan, D. L., Flake, G. P., Kirby, P. J., and Palmer, S. M. (2008). Respiratory toxicity of diacetyl in C57Bl/6 mice. Toxicol. Sci. 103, 169-180]. Finley BL, Galbraith DA, Weill D. Toxicol Sci. 2008; 105 (2): 429-32; author reply 433-4
• Diacetyl and bronchiolitis obliterans. Galbraith DA, Weill D. Am J Respir Crit Care Med. 2008; 178 (3): 313; author reply 313-4
• Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation. Valentine VG, Weill D, Gupta MR, Raper B, Laplace SG, Lombard GA, Bonvillain RW, Taylor DE, Dhillon GS. J Heart Lung Transplant. 2008; 27 (8): 875-81
• Heart and lung transplantation in the United States, 1997-2006. Mulligan MS, Shearon TH, Weill D, Pagani FD, Moore J, Murray S. Am J Transplant. 2008; 8 (4 Pt 2): 977-87
• Diagnosis and initial management of nonmalignant diseases related to asbestos. Weill D, Weill H. Am J Respir Crit Care Med. 2005; 171 (5): 527-8; author reply 528-30
• Pulmonary capillaritis in lung transplant recipients: treatment and effect on allograft function. Astor TL, Weill D, Cool C, Teitelbaum I, Schwarz MI, Zamora MR. J Heart Lung Transplant. 2005; 24 (12): 2091-7
• Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. J Heart Lung Transplant. 2005; 24 (10): 1454-9
• Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation. Zamora MR, Nicolls MR, Hodges TN, Marquesen J, Astor T, Grazia T, Weill D. Am J Transplant. 2004; 4 (10): 1635-42
• Standardized guidelines for surveillance bronchoscopy reduce complications in lung transplant recipients. Dransfield MT, Garver RI, Weill D. J Heart Lung Transplant. 2004; 23 (1): 110-4
• Extracorporeal photopheresis in lung transplantation. Astor TL, Weill D. J Cutan Med Surg. 2003 Jul-Aug; 7 (4 Suppl): 20-4
• Combination prophylaxis with ganciclovir and cytomegalovirus (CMV) immune globulin after lung transplantation: effective CMV prevention following daclizumab induction. Weill D, Lock BJ, Wewers DL, Young KR, Zorn GL, Early L, Kirklin JK, McGiffin DC. Am J Transplant. 2003; 3 (4): 492-6
• Pulmonary transplantation for advanced bronchioloalveolar carcinoma. Zorn GL, McGiffin DC, Young KR, Alexander CB, Weill D, Kirklin JK. J Thorac Cardiovasc Surg. 2003; 125 (1): 45-8
• A positive donor gram stain does not predict outcome following lung transplantation. Weill D, Dey GC, Hicks RA, Young KR, Zorn GL, Kirklin JK, Early L, McGiffin DC. J Heart Lung Transplant. 2002; 21 (5): 555-8
• Donor criteria in lung transplantation: an issue revisited. Weill D, Chest. 2002; 121 (6): 2029-31
• A positive donor gram stain does not predict the development of pneumonia, oxygenation, or duration of mechanical ventilation following lung transplantation. Weill D, Dey GC, Young KR, Zorn GL, Early LJ, Hicks RA, Kirklin J, McGiffin DC. J Heart Lung Transplant. 2001; 20 (2): 255
• Lung transplantation for emphysema: two lungs or one. Weill D, Keshavjee S. J Heart Lung Transplant. 2001; 20 (7): 739-42
• Management of congenital abnormalities of the donor lung. Schmidt F, McGiffin DC, Zorn G, Young KR, Weill D, Kirklin JK. Ann Thorac Surg. 2001; 72 (3): 935-7
• Role of cytomegalovirus in cardiac allograft vasculopathy. Weill D, Transpl Infect Dis. 2001: 3 Suppl 2 44-8
• Adenoviral-mediated p53 gene transfer to non-small cell lung cancer through endobronchial injection. Weill D, Mack M, Roth J, Swisher S, Proksch S, Merritt J, Nemunaitis J. Chest. 2000; 118 (4): 966-70
• Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. Nemunaitis J, Swisher SG, Timmons T, Connors D, Mack M, Doerksen L, Weill D, Wait J, Lawrence DD, Kemp BL, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Nguyen DM, Nesbitt JC, Perez-Soler R, Pisters KM, Putnam JB, Richli WR, Shin DM, Walsh GL, Merritt J, Roth J. J Clin Oncol. 2000; 18 (3): 609-22
• Comparison of the efficacy and cost-effectiveness of pre-emptive therapy as directed by CMV antigenemia and prophylaxis with ganciclovir in lung transplant recipients. Weill D, Zamora MR. J Heart Lung Transplant. 2000; 19 (8): 815-6
• The utility of open lung biopsy following lung transplantation. Weill D, McGiffin DC, Zorn GL, Alexander CB, Early LJ, Kirklin JK, Young KR. J Heart Lung Transplant. 2000; 19 (9): 852-7
• Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema. Weill D, Torres F, Hodges TN, Olmos JJ, Zamora MR. J Heart Lung Transplant. 1999; 18 (11): 1080-7
• Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. Swisher SG, Roth JA, Nemunaitis J, Lawrence DD, Kemp BL, Carrasco CH, Connors DG, El-Naggar AK, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Mack M, Merritt JA, Nguyen DM, Nesbitt JC, Perez-Soler R, Pisters KM, Putnam JB, Richli WR, Savin M, Schrump DS, Shin DM, Shulkin A, Walsh GL, Wait J, Weill D, Waugh MK. J Natl Cancer Inst. 1999; 91 (9): 763-71
• Adverse effects of medications commonly administered to thoracic surgical patients. Weill D, Mack MJ, Tennison D. Chest Surg Clin N Am. 1998; 8 (3): 681-702, x
• Pulmonary capillaritis: a possible histologic form of acute pulmonary allograft rejection. Badesch DB, Zamora M, Fullerton D, Weill D, Tuder R, Grover F, Schwarz MI. J Heart Lung Transplant. 1998; 17 (4): 415-22
• XO increases neutrophil adherence to endothelial cells by a dual ICAM-1 and P-selectin-mediated mechanism. Terada LS, Hybertson BM, Connelly KG, Weill D, Piermattei D, Repine JE. J Appl Physiol. 1997; 82 (3): 866-73
• Colon perforation after lung transplantation. Beaver TM, Fullerton DA, Zamora MR, Badesch DB, Weill D, Brown JM, Campbell DN, Grover FL. Ann Thorac Surg. 1996; 62 (3): 839-43